




 COPD is common and costly. 1-3 Nationally, the  . 10 million adults with physician-diagnosed COPD 
had an estimated 1.5 million ED visits and 726,000 hos-
pitalizations in 2000. 1 The Centers for Disease Control 
and Prevention has called for increased analysis and 
dissemination of COPD-related public health data. 4 
We addressed this information gap by characterizing 
patterns in health-care use in COPD using a compre-
hensive population-based framework. 
 Materials and Methods 
 Data Sources 
 Statewide ED visit data from January 1, 2008, through Decem-
ber 31, 2009, were obtained from the North Carolina Public Health 
Data Group and the North Carolina Disease Event Tracking and 
Epidemiologic Collection Tool (NC DETECT) surveillance sys tem. 
Through legislative mandate, all North Carolina acute care, hospital-
affi liated civilian EDs that are open 24/7 in North Carolina are 
required to provide data on all ED visits to the NC DETECT sur-
veillance system at least daily. Hospitals perform their own medical 
coding for administrative purposes then securely transmit electronic 
data streams to a data aggregator using standardized health record 
data formats. Data are monitored regularly, and data quality issues 
are communicated back to hospitals for resolution. Some 99.5% of 
all ED visits in North Carolina were captured from 110 out of 112 
(98%) eligible hospitals in 2008 and from 111 out of 114 (97%) hos-
pitals in 2009. 5,6 Age- and sex-stratifi ed population denominators for 
the population   45 years of age were derived from midyear popula-
tion estimates for each study year. 7 Institutional review board (IRB) 
approval (University of North Carolina IRB #10-1423) and a data 
use agreement were obtained from the University of North Carolina 
IRB and the North Carolina Division of Public Health, respectively. 
 Background:  Little is known about the population-based burden of ED care for COPD. 
 Methods:  We analyzed statewide ED surveillance system data to quantify the frequency of COPD-
related ED visits, hospital admissions, and comorbidities. 
 Results:  In 2008 to 2009 in North Carolina, 97,511 COPD-related ED visits were made by 
adults   45 years of age, at an annual rate of 13.8 ED visits/1,000 person-years. Among patients with 
COPD (n  5 33,799), 7% and 28% had a COPD-related return ED visit within a 30- and 365-day 
period of their index visit, respectively. Compared with patients on private insurance, Medicare, Med-
icaid, and noninsured patients were more likely to have a COPD-related return visit within 30 and 
365 days and have three or more COPD-related visits within 365 days. There were no differences in 
return visits by sex. Fifty-one percent of patients with COPD were admitted to the hospital from the 
index ED visit. Subsequent hospital admission risk in the cohort increased with age, peaking at 
65 to 69 years (risk ratio [RR], 1.41; 95% CI, 1.26-1.57); there was no difference by sex. Patients with 
congestive heart failure (RR, 1.29; 95% CI, 1.22-1.37), substance-related disorders (RR, 1.35; 95% CI, 
1.13-1.60), or respiratory failure/supplemental oxygen (RR, 1.25; 95% CI, 1.19-1.31) were more likely 
to have a subsequent hospital admission compared with patients without these comorbidities. 
 Conclusions:  The population-based burden of COPD-related care in the ED is signifi cant. Further 
research is needed to understand variations in COPD-related ED visits and hospital admissions. 
  CHEST 2013; 144(3):784–793 
 Abbreviations:  CCS  5 Clinical Classifi cation Software; ICD-9-CM  5  International Classifi cation of Diseases, Ninth 
Revision, Clinical Modifi cation ; IRB  5 institutional review board; NC DETECT  5 North Carolina Disease Event Tracking 
and Epidemiologic Collection Tool; RR  5 risk ratio 
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 Measures of COPD Care in the ED: Return Visits and 
Hospital Admissions 
 We calculated the number and proportion of patients with the 
following: (1) a subsequent COPD-related ED visit (a “return” visit) 
to the same facility within 30 days, (2) a return visit within 365 days of 
the index visit, and (3) three or more COPD-related ED visits within 
365 days of their index visit. Most of the patients either had the 
index visit alone or had two visits (ie, the index visit plus one sub-
sequent visit) in 365 days. Only 11.7% of patients had three or more 
visits, and just 5.8% had four or more visits. Thus, the number of 
patients with three or more COPD-related ED visits was already 
small, and further subdividing this group would not provide mean-
ingful analyses (e-Table 3). Last, we computed the likelihood of 
having a hospital admission from the ED at a subsequent ED visit. 
The likelihoods and related risk ratios (RRs) were computed using 
log-binomial regression. 
 Comorbidities 
 For each cohort member, we created a set of comorbidity indi-
cators based on ICD-9-CM diagnosis codes present in any of the 
11 diagnosis positions at the index visit. To group individual ICD-
9-CM codes into clinically informative diagnosis groups, we used 
a modifi ed version of the Clinical Classifi cation Software (CCS), 11 
which has been validated with ED data. 12 To focus on certain dis-
ease groups or comorbid conditions of interest, we modifi ed the 
CCS a priori by combining some related CCS groups and subset-
ting others. The full list of comorbid condition groups used in the 
study, and their corresponding CCS group numbers, may be found 
in e-Table 4. For example, the CCS “respiratory failure/supple-
mental oxygen/shortness of breath” classification in e-Table 4 
includes six CCS groups and encompasses ICD-9-CM diagnosis 
codes for respiratory failure, shortness of breath, supplemental 
oxygen, and respiratory distress/insuffi ciency, as well as some other 
respiratory symptoms and illnesses (see e-Table 4 for details). This 
group is distinct from other CCS groups involving respiratory con-
ditions, such as the CCS groups for pneumonia, upper respiratory 
infection, asthma, or bronchitis. To quantify the association of 
tobacco smoking and COPD-related ED visits, we also created a 
group “Tobacco use” that includes only ICD-9-CM codes 305.1x 
and V15.82 and is a subset of CCS group 663 (“Screening and 
history of mental health disease and substance abuse codes”). 
“Substance-related disorders” includes drug-induced mental dis-
orders and both dependent and nondependent abuse of drugs 
such as marijuana, cocaine, and opioids. 
 Statistical Analysis 
 We calculated the frequency and proportion of COPD-related 
ED visits by age, sex, payment method, discharge disposition, and 
comorbidities. Medicare is federal public medical insurance for 
those   65 years of age; Medicaid targets low-income individuals, 
families, and disabled individuals of all ages. Simple annual visit 
rates by age and sex were computed with state-level Census popu-
lation denominators. Using the “GENMOD” procedure in SAS 
version 9.2 (used to run generalized linear models), we estimated 
crude and adjustedRRs and 95% CIs with log-binomial regression 
models. Models were checked for convergence and goodness of fi t. 
 Results 
 Demographic Characteristics of 
COPD-Related ED Visits 
 In North Carolina in 2008 to 2009, 97,511 COPD-
related ED visits were made by adults aged   45 years. 
 Study Design and Cohort Defi nition 
 We described the frequency and rates of COPD-related ED 
visits and applied a population-based retrospective cohort design . 
We identifi ed all patients   45 years of age who had at least one 
COPD-related ED visit between January 1, 2008, and December 31, 
2008. We defi ned COPD-related ED visits as those in which the 
fi rst or second discharge diagnosis positions contained one of the 
following  International Classifi cation of Diseases, Ninth Revision, 
Clinical Modifi cation (ICD-9-CM) codes: 491.xx (chronic bron-
chitis), 492.xx (emphysema), 493.2x (chronic obstructive asthma), 
494.xx (bronchiectasis), or 496.xx (chronic airway obstruction, not 
elsewhere classifi ed). We chose not to include 490.xx (bronchitis, 
not specifi ed as acute or chronic) to reduce possible inclusion of 
patients without diagnosed COPD. 8 
 As a sensitivity analysis, we considered the following: (1) a broader 
COPD defi nition that adds two ICD-9-CM codes: 490.xx (bronchi-
tis, not specifi ed as acute or chronic) and 495.xx (extrinsic allergic 
alveolitis) and removes 493.2 (chronic obstructive asthma); 9,10 and 
(2) a narrower COPD defi nition with the fi rst discharge diagnosis 
position only (e-Table 1). With the broader defi nition, there were 
more visits in the younger age groups (45-49 years and 50-54 years), 
less Medicaid payment, and fewer ED discharges to the hospital. 
With the narrower defi nition, we found similar distributions with 
our COPD defi nition for age group, sex, ED disposition, and pay-
ment method. The most common diagnosis groups in the fi rst 
position, when COPD was in the second diagnostic position, were 
“other lower respiratory disease,” pneumonia, and “respiratory 
failure; insuffi ciency; arrest” (e-Table 2). These fi ndings support 
our defi nition, with COPD in either the fi rst or second discharge 
diagnosis position. 
 The index visit was defi ned as the fi rst COPD-related ED visit 
made by the patient to a given facility during calendar year 2008. 
ED patients (n  5 2,264) were excluded from the cohort if they 
had an index visit disposition of “died” (n  5 113), “unknown/missing” 
(n  5 2,117), or “other” (n  5 34). 
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The incidence rate was 13.78 ED visits/1,000 person-
years ( Table 1 ). The highest numbers of visits were 
found in the 65 to 69 years (14,001 or 14.4%) and 60 to 
64 years (13,413 or 13.8%) age groups. Incidence rates 
were highest among the older age groups 75 to 79, 80 
to 84, and 85 to 89 years. Women made more visits 
than men. Both the number of visits and incidence rates 
were higher among younger women (45-64 years) com-
pared with younger men (e-Table 5). At older ages 
(  75 years), the number of visits was still higher among 
women, but incidence rates were higher among men 
(e-Table 5). Payment method varied by age, with higher 
rates of noninsured (self-pay) and private insurance 
among the younger age group (45-64 years). Medicare 
 Table 1— Characteristics of COPD-Related ED Visits by Patients   45 Years Old in North Carolina, 2008-2009 
Population Characteristic 




Simple Annual Rate 
(per 1,000 person-y) c 
COPD Cohort d 
2008-2009, No. (%)
Age, y
 45-49 8,650 (8.9) 1,383,457 6.25 2,920 (8.6)
 50-54 11,153 (11.4) 1,274,170 8.75 3,647 (10.8)
 55-59 11,776 (12.1) 1,120,570 10.51 3,985 (11.8)
 60-64 13,413 (13.8) 955,150 14.04 4,510 (13.3)
 65-69 14,001 (14.4) 722,638 19.37 4,684 (13.9)
 70-74 12,488 (12.8) 562,630 22.20 4,403 (13.0)
 75-79 11,107 (11.4) 438,742 25.32 4,000 (11.9)
 80-84 8,284 (8.5) 325,473 25.45 3,090 (9.1)
 85-89 4,727 (4.9) 191,348 24.70 1,766 (5.2)
 90 1 1,912 (2.0) 103,303 18.51 794 (2.3)
Sex
 Female 54,053 (55.4) 3,815,603 14.17 18,797 (55.6)
 Male 43,447 (44.6) 3,261,878 13.32 14,993 (44.4) e 
 Unknown/missing 11 (0.0) NA … …
Payment method
 Noninsured
  Self-pay (no insurance) 8,465 (8.7) … … 2,919 (8.6)
 Insured
  Private insurance 13,810 (14.2) … … 5,283 (15.6)
  Medicare 57,396 (58.9) … … 19,879 (58.8)
  Medicaid 10,499 (10.8) … … 3,127 (9.3)
  Other government 
  payments/workers’ compensation
1,039 (1.1) … … 410 (1.2)
 Other/unknown/missing 6,302 (6.5) … … 2,181 (6.5)
ED disposition f 
 Discharged to home or self-care 43,262 (44.4) … … 15,096 (44.7)
 Admitted to a hospital department 45,146 (46.3) … … 17,302 (51.2)
 Left without treatment or against 
  medical advice
756 (0.8) … … 246 (0.7)
 Transferred to another location for 
  additional care g 
2,208 (2.3) … … 824 (2.4)
 Placed in observation (not admitted) 863 (0.9) … … 331 (1.0)
 Died 270 (0.3) … … NA
 Other 211 (0.2) … … NA
 Unknown/missing 4,795 (4.9) … … NA
Total 97,511 7,077,481 13.78 33,799
ICD-9-CM  5  International Classifi cation of Diseases, Ninth Revision, Clinical Modifi cation ; NA  5 not applicable.
 a ED visits associated with COPD are defi ned as having an ICD-9-CM codes 491.xx , 492.xx, 493.2, 494.xx, or 496.xx as the fi rst or second 
diagnosis.
 b Combined 2008 and 2009 midyear population estimates for the North Carolina population aged   45 y.
 c Simple annual rate is an unadjusted rate, calculated from total number of visits in 2008 to 2009 divided by North Carolina population   45 y old 
2008 to 2009.
 d COPD patient cohort, N  5 33,799.
 e Suppressed due to cell size   10.
 f Disposition values presented in the last column refer only to the cohort members’ index visits. The NA that is listed for ED dispositions of “Died,” 
“Other,” and “Unknown/missing” are exclusions for cohort memberships.
 g Transfer locations include “another short-term general hospital,” ”skilled nursing facility,” “intermediate care facility,” “another type of institution,” 
“home, under care of a home IV drug therapy provider,” and “home, under care of certifi ed home care provider/program.”
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payment was used by 80.5% of those aged   65 years 
(e-Table 6). 
 COPD Patient Cohort and Return ED Visits 
 The COPD patient cohort (n  5 33,799) had a similar 
distribution of age and sex compared with the visit-
based description ( Table 1 ). Within this cohort, 7% 
and 28%, respectively, had a COPD-related ED return 
visit within a 30-day and 365-day period; 12% had 
three or more COPD-related visits within 365 days of 
their index visit ( Table 2 ). Patients   80 years of age 
were less likely to have one or more return visits within 
365 days. Patients   90 years of age were less likely to 
have a return visit within 30 days. There were no dif-
ferences among women and men in frequency of return 
visits. Compared with patients on private insurance, 
patients with Medicare or Medicaid, the noninsured, 
or those whose payment method was unknown were 
more likely to have the following: (1) a COPD-related 
return visit within 30 or 365 days, and (2) three or 
more COPD-related visits within 365 days (RRs all 
statistically signifi cant ). 
 Index Hospital Admissions 
 Fifty-one percent of the COPD patient cohort was 
admitted to the hospital from the ED at their index 
visit. Compared with patients discharged to home at 
their index visit, patients admitted to the hospital were 
statistically signifi cantly less likely to have a subsequent 
ED visit in a 30- or 365-day period or to have three or 
more ED visits within 365 days ( Table 2 ). However, 
patients admitted to the hospital directly from the ED 
at their index visit were at increased risk (RR, 1.43; 
95% CI, 1.36-1.5) to have a subsequent hospital admis-
sion within 365 days of their index visit, compared with 
those who were discharged to home at their index 
visit ( Table 2 ). 
 Subsequent Hospital Admissions 
 Within the patient cohort, 16.8% had one or more 
subsequent COPD-related ED visits that resulted in 
hospital admission within 365 days of the index visit. 
The RR of having a subsequent hospital admission 
increased with age from 45 to 60 years, plateaued from 
60 to 79 years with a statistically signifi cant increase 
risk (RR range from 1.38-1.41) compared with those 
45 to 49 years, then decreased for those aged   80 years 
and older ( Fig 1 ). No differences in subsequent hos-
pital admissions were found by sex. Patients enrolled 
in Medicare and Medicaid were 29% and 35% more 
likely, respectively, to have one or more subsequent 
hospital admissions compared with those with private 
insurance. Patients with no insurance were 28% less 
likely than the privately insured to have a subsequent 
hospital admissions. 
 Comorbidity Analysis and Return Visits 
 The fi ve most common comorbidities among the 
cohort were hypertension (42%), respiratory fail-
ure/supplemental oxygen/shortness of breath (37%), 
heart disease (30%), tobacco use (29%), diabetes (29%), 
and congestive heart failure (21%) ( Table 2 ). Patients 
with COPD with a respiratory failure/supplemental 
oxygen/shortness of breath comorbidity were at sta-
tistically significant increased risk of a subsequent 
COPD-related ED return visit within 30 days and 
365 days as well as three or more COPD-related visits 
within 365 days, compared with those without this 
comorbidity. Those with diabetes and congestive heart 
failure comorbidities were also at increased risk of 
one or more subsequent COPD-related ED visits within 
365 days. Those with pneumonia comorbidity were less 
likely to have a return visit in 30 days or three or more 
return visits within 365 days. 
 Subsequent Hospital Admissions:  There were sub-
stantial differences in subsequent hospital admis-
sion risk among those with and without comorbidities. 
Nine of the 15 comorbidities were signifi cantly asso-
ciated with increased risk of subsequent hospital 
admissions within 365 days (RRs ranging from 1.11 to 
1.35) ( Table 3 ). Compared with those without these 
comorbidities, patients with congestive heart failure or 
substance-related disorders had the highest RRs for 
subsequent hospital admissions, followed by respira-
tory failure/supplemental oxygen/shortness of breath 
and cardiac dysrhythmias/cardiac arrest/ventricular 
fi brillation CCS comorbidities. In contrast, patients 
with comorbidities of upper respiratory infection or 
COPD “other” (bronchitis unspecifi ed acute/chronic, 
ICD-9-CM 490.x) were statistically signifi cantly less 
likely to have one or more hospital admissions within 
365 days of the index visit. Patients with COPD with 
recorded tobacco use at the index visit were not at 
statistically signifi cant higher risk of having one or more 
subsequent hospital admissions. 
 Discussion 
 Little population-based research has been conducted 
to estimate the burden of COPD-related ED visits. 
NC DETECT, a surveillance system that captures 
99.5% of ED visits in North Carolina, provided an 
excellent opportunity to characterize COPD-related 
ED visits among a large population. We found that the 
COPD-related ED visit rate of 13.8 per 1,000 person-
years among adults 45 years and older for 2008 to 
2009 was higher than a national average of 8.72 per 
1,000 person-years for 1992 to 2000 for adults   25 years 
of age. 13 Our estimate was very similar to the 13.16 (per 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































journal.publications.chestnet.org CHEST / 144 / 3 / SEPTEMBER 2013  789 
but lower than the study by Rosychuk et al, 14 which 
included those   55 years of age (25.6/1,000). Differ-
ences between our rates and previous estimates are 
likely infl uenced by the study’s age distribution, COPD 
defi nition, and temporal increases in disease. 
 ED Visits 
 Our fi ndings related to multiple ED visits were mixed 
compared with previous reports in US and Canadian 
EDs. We found patients on Medicare or Medicaid or 
noninsured patients were consistently more likely to 
have subsequent 30-day, 365-day, and multiple COPD 
ED visits within 365 days. Although Tsai et al 15 simi-
larly found Medicaid was associated with increased 
COPD ED visits, “other public (all Canadian and 
Medicare)” insurance was not. Similar to Watson et al, 16 
we found no sex differences for ED visits. 
 Hospital Admissions 
 Fifty-one percent of the cohort of patients with 
COPD was admitted to the hospital from the ED at 
the index visit. This percentage is twice as large as the 
overall hospitalization percentage for all ED visits 
made by patients aged   45 years in the NC DETECT 
data (25.8%). Regarding subsequent hospital admis-
sions, older age was associated with increased likeli-
hood of hospital admission, 17 although in our study, 
the increased risk plateaued at ages 65 to 79 years. 
Again, similar to Watson et al, 16 we did not fi nd sex 
differences in subsequent hospital admission. In our 
study, public insurance (Medicaid, Medicare) was asso-
ciated with increased likelihood of subsequent hospital 
admission; whereas Tsai et al 17 found neither Medic-
aid nor “other public” insurance was associated with 
hospital admissions, which may suggest that these fac-
tors affect initial and subsequent hospital admissions 
differently. 
 Similar to Watson et al, 16 we found no sex differ-
ences for hospitalizations. In contrast, Tsai et al 17 found 
women at higher risk (RR, 2.3) of hospital admission, 
whereas Gonzalez et al 18 found men at a higher risk of 
a COPD rehospitalization (hazard ratio, 1.12; 95% CI, 
1.09-1.15). The variations in the published literature 
may be driven by differences in the severity and man-
agement of COPD in the various cohorts as well as sec-
ular trends in tobacco smoking among men and women. 
 Comorbidities 
 The prevalence of various comorbidities can vary 
by characteristics of the cohort and coding practices 
in the ED. In the literature, some cohorts have a very 
high prevalence of hypertension (63.4%), 19 whereas 
others, including ours (42%), are within the 40% to 






























































































































































































































































































































































































































































































































































































































































































































































































hospital admissions (OR, 0.45; 95% CI, 0.25-0.80) 15 ; 
similarly, we found cohort members with a “COPD-
other” comorbidity (490.x, bronchitis, not specifi ed 
as acute or chronic), at less risk of subsequent hospi-
tal admission. 
 Interestingly, “substance-related disorders” comor-
bidity, although present in only a small percentage (1.5%, 
512 of 33,799) of the cohort, had the largest associ-
ation with increased subsequent hospital admission 
among the comorbidities we examined. In examining 
the ICD-9-CM codes within the substance-related 
disorders cluster more closely, cocaine use (305.60) 
was the most frequent (23.5%), followed by “other, 
mixed or unspecifi ed drug abuse” (305.90). We are 
unaware of published research that has directly shown 
such an association. We speculate the reasons for this 
increased hospital admission risk are multifaceted—
substance abuse affects physical health and impedes 
access to care. 25,26 We suggest further investigation of 
the relationship between substance-related disorders 
and COPD-related ED visits. 
 There are several limitations in our study. First, 
detailed clinical data (eg, spirometry, blood gas mea-
surements, GOLD [Global Initiative for Chronic 
Obstructive Lung Disease outcomes] 2 ) were not avail-
able. Using ICD-9-CM codes alone without clinical 
data, some patients with COPD could be misclassi-
fi ed. However, these detailed codes (491, 492, 496) 
have been shown to have good sensitivity (85%) and 
modest specifi city (78.4%). 8,27 Second, we chose to 
  
 Figure 1. Cohort risk of COPD hospital admission, by age . 
of 21% was substantially higher than the 5% to 7% in 
Soriano et al 23 and Curkendall et al 22 but closer to the 
15% found by Tsai et al. 15 Some of these differences 
are likely due to the proportion of one sex vs another 
among the cohorts; other differences may be due to 
variations in ED coding practices. 
 “Respiratory failure/supplemental oxygen/shortness 
of breath” and congestive heart failure were two of 
the comorbidities with the largest association with 
increased hospital admissions; a “COPD other” comor-
bidity was associated with decreased hospital admis-
sions. Our pneumonia comorbidity hospital admission 
RR (1.11) was comparable, although smaller in mag-
nitude, with Tsai et al 17 and Soriano et al. 23 Tsai et al 17 
found that patients with pneumonia as a concomi-
tant diagnosis were 4.87 (95% CI, 2.01-11.82) times 
as likely to be admitted to the hospital. Similarly, 
Soriano et al 23 found patients with newly diagnosed 
COPD at higher risk for pneumonia comorbidity within 
the fi rst year of diagnosis (RR, 16.0). Patients with a 
CCS congestive heart failure or “cardiac dysrhyth-
mia/arrest/ventricular fi brillation” comorbidity group-
ing were 1.29 (95% CI, 1.22-1.37) and 1.20 (95% CI, 
1.12-1.28) times as likely to be subsequently admit-
ted to the hospital, respectively. These estimates are 
slightly lower than those from Dalal et al 24 for patients 
with cardiovascular disease comorbidities—they were 
1.62 (95% CI, 1.40-1.88) times as likely to be admit ted 
to the hospital. Patients with “mixed” COPD/asthma 
diagnoses have been shown to be less likely to have 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































defi ne a COPD-related visit when a COPD diagnos-
tic code appeared in the fi rst or second position. This 
decision was made using both previously reported 
approaches 8-10,27 and our sensitivity analysis using both 
a narrower and broader defi nition. Third, our study 
was conducted in North Carolina and may not be 
entirely representative of the pattern of COPD-related 
ED care for the nation. Adult smoking in NC is slightly 
higher than in the rest of the United States (19.8% 
vs 17.4%). 28 However, the proportion who are   65 years 
of age is nearly equal to that of the country as a whole 
(13.2% vs 13.3%). 29 Last, we are using secondary data, 
which are subject to general limitations, including 
potential coding errors, missing information, and changes 
in coding practices. For example, the use of the ICD-
9-CM code for tobacco use has increased in recent 
years in NC DETECT ED visit data. Unlike a pri-
mary data collection effort, we are not able to defi ni-
tively confi rm whether the absence of a diagnosis 
code for a specifi c comorbidity means that the patient 
truly did not have that condition. However, several 
factors lend support to the validity and completeness 
of our comorbidity assessments: (1) provision of diag-
nosis codes is required for a hospital to be in compli-
ance with the NC DETECT system; (2) diagnosis 
codes are used for billing purposes, so providers have 
a reimbursement incentive to provide full diagnoses; 
and (3) up to 11 diagnosis codes for each ED visit are 
collected and updated codes are accepted by NC 
DETECT. 
 Despite these limitations, a major strength of this 
research was the population-based nature of these 
surveillance system data; we characterized the bur-
den of COPD-related ED care for a population of 
9 million. The size of our study cohort was larger than 
many clinic-based studies 20,23 and allowed suffi cient 
statistical power to assess demographic variations in 
return ED visits, hospital admissions, and comorbidi-
ties. Existing national estimates have primarily been 
based on the Multicenter Airway Research Collabo-
ration (MARC), with 29 EDs in 15 US states and 
three Canadian provinces, self-report interviews, and 
2-week follow-up. 15,30 In contrast, our estimates are 
based on administrative data from 110 to 111 EDs in 
rural and urban regions from one US state over a 2-year 
period. Both study designs are informative, and any 
differences in the results may refl ect advantages or 
disadvantages of each approach. 
 We quantifi ed estimates of COPD-related ED visits, 
return visits, hospital admissions, and comorbidities 
in the population. A high burden of COPD-related 
ED care was found for both repeat ED visits and hos-
pital admissions. Next steps include both (1) further 
investigating the substance-related disorder comor-
bidity fi nding, and (2) conducting a validation of the 
case defi nition with chart reviews in a random sample 
of EDs within the NC DETECT system. Our research 
helps fi ll the information gap on the population-based 
burden of COPD-related ED care. 
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